Effects of atorvastatin treatment on global fibrinolytic capacity, apoptosis, and leukocyte activation in patients with coronary artery disease

被引：0
|
作者：
Atalar, E
Acyl, T
Aytemir, K
Haznedaroglu, Y
Özer, N
Daver, A
Övünç, K
Aksöyek, S
Kes, S
Özmen, F
机构：
[1] Hacettepe Univ, Sch Med, Dept Cardiol, Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Hematol, Ankara, Turkey
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2001年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：267A / 267A
页数：1
相关论文
共 50 条
  • [1] Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease
    Atalar, E
    Ozmen, F
    Haznedaroglu, I
    Açil, T
    Ozer, N
    Ovünç, K
    Aksöyek, S
    Kes, S
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 84 (2-3) : 227 - 231
  • [2] Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease
    Sakamoto, T
    Kaikita, K
    Miyamoto, S
    Kojima, S
    Sugiyama, S
    Yoshimura, M
    Ogawa, H
    CIRCULATION JOURNAL, 2004, 68 (03) : 232 - 235
  • [3] Global fibrinolytic capacity in coronary artery ectasia
    Dogan, A
    Tunc, B
    Gedikli, O
    Ayata, A
    Nazli, C
    Altinbas, A
    Ergene, O
    EUROPEAN HEART JOURNAL, 2002, 23 : 417 - 417
  • [4] Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: Global fibrinolytic capacity
    Abdullah Dogan
    Bahattin Tunc
    Oktay Ergene
    Mehmet Ozaydin
    Cem Nazli
    Ahmet Altinbas
    Omer Gedikli
    The International Journal of Cardiovascular Imaging, 2003, 19 : 465 - 471
  • [5] Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: Global fibrinolytic capacity
    Dogan, A
    Tunc, B
    Ergene, O
    Ozaydin, M
    Nazli, C
    Altinbas, A
    Gedikli, O
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2003, 19 (06): : 465 - 471
  • [6] Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia
    Stein, D
    Heins, M
    Schoebel, FC
    Pels, K
    Jax, TW
    Stiegler, H
    Reinauer, H
    Strauer, BE
    Leschke, M
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (05) : 970 - 974
  • [7] Prothrombotic and global T lymphocyte activation in stable coronary artery disease patients, effect of atorvastatin
    Alber, H
    Dörler, J
    Frick, M
    Dichtl, W
    Zwick, R
    Pachinger, O
    Weidinger, F
    EUROPEAN HEART JOURNAL, 2004, 25 : 602 - 603
  • [8] The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients
    Örem, C
    Uydu, HA
    Yilmaz, R
    Gokçe, M
    Baykan, M
    Eminagaoglu, S
    Örem, A
    JAPANESE HEART JOURNAL, 2004, 45 (06): : 977 - 987
  • [9] The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease
    Yildiz A.
    Cakar M.A.
    Baskurt M.
    Okcun B.
    Guzelsoy D.
    Coskun U.
    Cardiovascular Ultrasound, 5 (1)
  • [10] Coronary leukocyte activation in relation to progression of coronary artery disease
    Marijke A. de Vries
    Arash Alipour
    Erwin Birnie
    Andrew Westzaan
    Selvetta van Santen
    Ellen van der Zwan
    Anho H. Liem
    Noëlle van der Meulen
    Manuel Castro Cabezas
    Frontiers of Medicine, 2016, 10 : 85 - 90
12345